Rifampicin (RIF) Monotherapy (4 months for Latent TB Infection)
Treatment used for 1 condition
Total Trials
25
Total Participants
20K
Avg Effectiveness
77%
Avg Safety Score
68%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.